Ziihera 300 mg lyophilized powder for injection Images
Generic Name: zanidatamab
This medication has been identified as Ziihera 300 mg lyophilized powder for injection. It is supplied by Jazz Pharmaceuticals plc.
Ziihera is used in the treatment of Biliary Tract Tumor and belongs to the drug class HER2 inhibitors. Ziihera 300 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ziihera
- Generic Name
- zanidatamab
- Strength
- 300 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- HER2 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jazz Pharmaceuticals plc
- National Drug Code (NDC)
- 68727-0950
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Herceptin Hylecta
Herceptin Hylecta is a type of targeted immunotherapy used in the treatment of human epidermal ...
Hercessi
Hercessi (trastuzumab-strf) is the 6th biosimilar to Herceptin to be granted FDA approval and may ...
Herzuma
Herzuma is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, esophageal ...
More about Ziihera (zanidatamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.